Press release
Novel algorithm for nano-MRI with Ferrotran® (Ferumoxtran) for the detection of even very small lymph nodes in head & neck cancer patients
SPL Medical announced today the publication and online availability of the full paper in Investigative Radiology about the use of Ferrotran® for the detection of even very small lymph nodes in patients with head & neck cancer. A new reading algorithm has been developed which is applicable to routine MRI instruments available in a big installed base in the market.Conclusions by the authors
Radiological analysis revealed that metastatic lymph nodes showed equal or higher MRI signal intensity when compared with lipid tissue on T2*-weighted MGRE sequence (15/16 lymph nodes; 94%), whereas healthy lymph nodes showed lower (17/19 lymph nodes; 89%) or complete attenuation of signal intensity (273/279; 98%) when compared with lipid tissue on T2*-weighted MGRE. Histopathology of all resected specimens identified 392 lymph nodes.
Outlook
With this new application, Nano-MRT with Ferrotran® is entering an additional indication market. It can fulfil the hitherto unmet need of reliable detection of small lymph node metastases in patients with head & neck cancer. Such a reliable detection is pivotal for patient treatment decisions.
Ferrotran® is available already now to patients within the running phase III trial PROSTAPROGRESS, but as well in a named-patient-use program in Nijmegen, Netherlands and in a compassionate use programme in Zurich, Switzerland.
"On top of the well-known use of Nano-MRI with Ferrotran® to detect even very small lymph node metastases in prostate cancer patients, this new indication can now enable access to another growing market segment in oncology", stated Dr. Jürgen Feuerstein, Chief Executive Officer of SPL medical.
SPLmedical BV
Dr. Juergen Feuerstein
Toernooiveld 100
6525 EC Nijmegen
The Netherlands
SPL medical is a spin-off of the Radboud university medical center and is funded additionally by Oost NL, a Dutch regional venture capital company, and b.e.imaging GmbH, a German company specialized in the development and commercialization of contrast agents
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Novel algorithm for nano-MRI with Ferrotran® (Ferumoxtran) for the detection of even very small lymph nodes in head & neck cancer patients here
News-ID: 2677659 • Views: …
More Releases from Saving Patients' Lives Medical B.V.
SPL Medical has entered into an Agreement with NanoEcho for supply and applicati …
Nijmegen, The Netherlands, 27.02.2024 - The business agreement, signed today by SPL Medical and NanoEcho, is a comprehensive contract. The agreement grants NanoEcho exclusivity regarding the supply of ferumoxtran (iron oxide-based nanoparticles) for use in magnetomotive ultrasound.
For the clinical effectiveness of the NanoEcho system, the choice of nanoparticles is of crucial im-portance. Ferumoxtran is chosen based on its unique ability to spread in the lymphatic system and differentiate between diseased…
SPL Medical announces achievement of next major clinical development milestone f …
Nijmegen, The Netherlands, 02.08.2023 - SPL medical has its proprietary iron-based nano-particle Ferrotran® (Ferumoxtran) product and platform in clinical Phase III. The pivotal trial named PROSTAPROGRESS has now reached the next major milestone by inclusion of over 75% of the patients into this trial.
Major academic centers in The Netherlands, Belgium, Germany and Switzerland are contributing constantly.
With the PROSTAPROGRESS trial, SPL will verify the superior efficacy and state-of-the-art safety of Ferrotran®,…
SPL Medical announces achievement of major Phase III clini-cal development miles …
Nijmegen, The Netherlands, 14.12.2022 - SPL medical has its proprietary iron-based nano-particle Ferrotran® (Ferumoxtran) product and platform in clinical Phase III. The pivotal trial named PROSTAPROGRESS has now reached a major milestone by inclusion of more than 50 % of the planned patient group into this trial.
Major academic centres in The Netherlands, Belgium, Germany and Switzerland are contributing constantly.
With the PROSTAPROGRESS trial, SPL will verify the superior efficacy and state-of-the-art…
More Releases for SPL
Structured Product Labeling (SPL)Software Market Size by Application, Type, Geog …
According to Market Research Intellect, the global Structured Product Labeling (SPL)Software market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The Structured Product Labeling (SPL) software market is witnessing steady growth due to rising regulatory requirements…
Structured Product Labeling (SPL) Software Market to See Competition Rise | Frey …
The latest research study released by Stratagem Market Insights on the "Structured Product Labeling (SPL) Software Market" with 100+ pages of analysis on business strategy taken up by emerging industry players, geographical scope, market segments, product landscape and price, and cost structure. It also assists in market segmentation according to the industry's latest and upcoming trends to the bottom-most level, topographical markets, and key advancement from both market and technology-aligned…
Global Heparin Sodium Market 2020, Shenzhen Hepalink, Bioibérica, Nanjing King- …
The report "Global Heparin Sodium Market" evaluates the present and future market opportunities of Heparin Sodium business. The analysis study sheds lightweight on a number of the main drivers and restraints factors influencing the expansion of the Heparin Sodium market. The market is separate on the idea of product sort, Heparin Sodium makers, application, and countries. practicableness of investment study, Heparin Sodium market standing from 2015 to 2020, Heparin Sodium…
Enterprise System Integrators Market 2018 | Top Players - AVI Systems, Red Threa …
Enterprise System Integrators Market Research Report
Enterprise System Integrators are professional organizations that provide systems integration products and services to customers, usually corporate or corporate.
This report studies the Enterprise System Integrators market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Enterprise System Integrators market by product type and applications/end…
Healthcare IT Integration Market Type, Services, End User, Applications, Top Key …
Healthcare IT Integration Market report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Healthcare IT Integration industry analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Worldwide Market Reports added Latest Research Report titled “Healthcare IT Integration Market by Manufacturers, Regions, Product Type and Application, Forecast to 2024” to its Large Report database.
Get…
Global Heparin Sodium Market 2017 - Nanjing King-friend, Pfizer, SPL, Dongcheng …
The worldwide Heparin Sodium Market report launched by Market.biz focuses on a complete and accurate study of Heparin Sodium industry. Global Heparin Sodium Market 2017 report is fundamentally concentrated on current scenario of Heparin Sodium market. This comprehensive research document will improve the efficiency of the Heparin Sodium market during the forecast period from 2017 to 2022.
The Heparin Sodium industry report covers different aspects of market such as Heparin Sodium…
